Brazil, on Thursday, approved the use of Chinese biopharmaceutical company Sinovac's COVID-19 vaccine for non-immunocompromised young people aged 6 to 17. The Brazilian Health Regulatory Agency, Anvisa, said it would evaluate the use of the Sinovac vaccine on children aged three to five once it obtained more data.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3